{
    "organizations": [],
    "uuid": "35d0fd51067e8f9485d77df2870ad35b53976dc8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-momenta-pharmaceuticals-q1-loss-pe/brief-momenta-pharmaceuticals-q1-loss-per-share-0-63-idUSASC0A0F0",
    "ord_in_thread": 0,
    "title": "BRIEF-Momenta Pharmaceuticals Q1 Loss Per Share $0.63",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Momenta Pharmaceuticals Inc:\n* MOMENTA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* Q1 LOSS PER SHARE $0.63 * REITERATING NON-GAAP OPERATING EXPENSE GUIDANCE OF ABOUT $180 - $220 MILLION FOR 2018 AND $45 - $55 MILLION FOR Q2 OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-08T19:25:00.000+03:00",
    "crawled": "2018-05-09T12:25:38.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "momentum",
        "pharmaceutical",
        "inc",
        "momentum",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "reiterating",
        "operating",
        "expense",
        "guidance",
        "million",
        "million",
        "q2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}